ASP015K

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy Subjects

Conditions

Healthy Subjects, Pharmacokinetics of ASP015K

Trial Timeline

Dec 1, 2009 → Jan 1, 2010

NCT ID

NCT01406132

About ASP015K

ASP015K is a phase 1 stage product being developed by Astellas Pharma for Healthy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT01406132. Target conditions include Healthy Subjects, Pharmacokinetics of ASP015K.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Subjects were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02586194	Phase 1	Completed	Dec 28, 2015	Sep 27, 2016	Patients With Impaired Hepatic Function
NCT02603497	Phase 1	Completed	Nov 24, 2015	Dec 19, 2016	Patients With Impaired Renal Function
NCT01929577	Phase 1	Completed	May 1, 2013	Aug 1, 2013	Bioavailability of ASP015K
NCT01484964	Phase 1	Completed	Sep 1, 2011	Oct 1, 2011	Pharmacokinetics of ASP015K
NCT01486017	Phase 1	Completed	Sep 1, 2011	Sep 1, 2011	Bioavailability of ASP015K
NCT01406132	Phase 1	Completed	Dec 1, 2009	Jan 1, 2010	Healthy Subjects

Competing Products

20 competing products in Healthy Subjects

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26